Zhejiang Jingxin Pharmaceutical Co.,Ltd.’s Net Profit Rose 0.1% in First Three Quarters of 2023

Zhejiang Jingxin Pharmaceutical Co.,Ltd. (浙江京新药业股份有限公司) (002020.SZ) reported a net profit of 476 million yuan in the first three quarters of 2023, up 0.1% year-on-year.

Meanwhile, the company posted 2.9 billion yuan in revenue, up 4.5% year-on-year.

At the end of the reporting period, it had 7.6 billion yuan in total assets and 2.2 billion yuan in total liabilities, with a liability-to-asset ratio of 29.3%.